Company intelligence / Profile preview
Camino Pharma
San Diego, California, United Statescaminopharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
SBP-9330, their lead candidate for nicotine cessation, has completed Phase 1 clinical testing showing favorable safety and tolerability profile with well-behaved pharmacokinetics in humans[6]
- Therapeutic areas
- OncologyPsychiatryNeurology
- Modalities
- Small molecule drugs
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Sanford Burnham Prebys Medical Discovery InstituteUniversity of California San Diego
Beyond the preview
Go deeper on Camino Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Camino Pharma.